Bitcoin Depot (BTM) – Reverse Stock Split


Tuesday, February 24, 2026

Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

BTM 1-for-7 reverse stock split. On February 23, 2026, the company’s Class A common stock began trading on a split-adjusted basis on Nasdaq. The action had been previously authorized by shareholders and approved by the Board and did not reflect any change in operating performance or strategy.

No alteration to economic ownership or fundamentals. Every seven shares outstanding were consolidated into one share, with fractional shares cashed out based on the pre-split VWAP. Authorized shares and par value remained unchanged, while public warrants, equity awards, and other convertible securities were adjusted proportionally, including a mechanical increase in the BTMWW warrant exercise price.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

CECO to Combine with Thermon in $2.2B Deal, Expanding Global Industrial Platform

CECO Environmental Corp. (Nasdaq: CECO) and Thermon Group Holdings, Inc. (NYSE: THR) have entered into a definitive agreement to combine in a stock and cash transaction valued at approximately $2.2 billion, creating a scaled industrial platform focused on mission-critical environmental and thermal solutions.

The combined company will operate under the CECO Environmental name and continue to be led by CEO Todd Gleason. Upon closing, CECO and Thermon shareholders are expected to own roughly 62.5% and 37.5% of the combined company, respectively.

The transaction adds Thermon’s industrial process heating, heat tracing, and temperature management technologies to CECO’s portfolio of environmental, emissions control, industrial air quality, and water treatment solutions. The result is a broader, more diversified platform serving energy, power generation, industrial, and infrastructure markets.

Thermon brings established capabilities in process heating systems that are widely used in energy infrastructure and industrial facilities. By integrating these technologies, CECO meaningfully expands its exposure to thermal management applications—an area tied to long-term trends such as energy transition, industrial reshoring, infrastructure buildout, and decarbonization initiatives.

Management from both companies emphasized the complementary nature of their offerings. CECO’s existing footprint in emissions control, air quality, and water treatment aligns with Thermon’s temperature management solutions, creating opportunities to serve customers across more components of their industrial systems.

The combined platform is expected to provide customers with integrated solutions designed to protect people, equipment, processes, and the environment—an increasingly important value proposition as regulatory standards tighten globally.

Under the terms of the agreement, Thermon shareholders may elect to receive a mix of cash and CECO stock, all-cash consideration, or all-stock consideration, subject to proration limits. The mixed consideration implies a per-share value of approximately $63.13 based on CECO’s February 23, 2026 closing price, representing a 26.8% premium to Thermon’s closing price the same day.

The companies expect to generate approximately $40 million in annual cost synergies within 36 months following the close of the transaction. In addition to cost efficiencies, the combined company is anticipated to benefit from a more balanced revenue mix, including greater exposure to short-cycle and aftermarket service revenues.

Scale also plays a central role. Larger industrial customers increasingly prefer suppliers capable of delivering comprehensive engineered solutions across multiple technical disciplines. The merger positions CECO to compete for larger, more complex projects while maintaining participation in recurring service and maintenance markets.

The transaction has been unanimously approved by both companies’ boards of directors and is expected to close in mid-2026, subject to customary closing conditions. Jason DeZwirek, Chairman of CECO, and related holders representing approximately 15.2% of CECO’s voting power have agreed to vote in favor of the deal, subject to certain exceptions.

Following completion, CECO’s board will include two members from Thermon’s current board, while executive leadership will remain under Gleason.

If completed, the transaction marks a significant step in CECO’s evolution into a broader industrial technology platform, combining environmental and thermal management capabilities under one publicly traded entity.

Gilead to Acquire Arcellx in $7.8B Bet on Next-Gen CAR-T Leadership

Gilead Sciences (Nasdaq: GILD) is doubling down on cell therapy. The Foster City–based biopharma announced it will acquire Arcellx (Nasdaq: ACLX) in a transaction valued at approximately $7.8 billion in equity value, giving Gilead full control of anitocabtagene autoleucel (anito-cel), an investigational BCMA-directed CAR T-cell therapy for multiple myeloma.

Kite, a Gilead company, has partnered with Arcellx since 2022 to co-develop and co-commercialize anito-cel. Under the new agreement, Gilead will acquire all outstanding shares of Arcellx it does not already own for $115 per share in cash, plus one non-transferable contingent value right (CVR) worth $5 per share if cumulative global net sales of anito-cel reach $6.0 billion from launch through year-end 2029.

The $115 cash component represents a 68% premium to Arcellx’s 30-day volume-weighted average share price as of February 20, 2026. Gilead already owns approximately 11.5% of Arcellx’s outstanding common stock. The transaction, approved by both companies’ boards, is expected to close in the second quarter of 2026, subject to customary conditions including the tender of a majority of outstanding shares, regulatory approvals and other standard closing requirements.

If completed, the acquisition would eliminate profit-sharing, milestone payments and royalty obligations tied to the existing collaboration, streamlining economics as Gilead prepares for potential commercialization.

The timing is notable. The U.S. Food and Drug Administration has accepted the Biologics License Application (BLA) for anito-cel as a fourth-line treatment for adult patients with relapsed or refractory multiple myeloma. The application is supported by results from a Phase 1 study and the pivotal Phase 2 iMMagine1 trial. The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of December 23, 2026.

In clinical studies to date, anito-cel has demonstrated deep and durable responses with a predictable and manageable safety profile, according to company disclosures. Multiple myeloma remains an area of high unmet need, particularly among heavily pretreated patients who often face diminishing responses, increasing toxicity and fewer therapeutic options over time.

Full ownership provides Gilead with greater flexibility to align development strategy, scale manufacturing through Kite, and potentially explore expansion into earlier lines of therapy, subject to clinical outcomes and regulatory review.

Beyond anito-cel, Gilead is also acquiring Arcellx’s D-Domain CAR platform, which has generated proprietary target-binding domains designed to improve specificity and binding affinity. The platform may support future CAR T-cell programs, bispecific constructs and in vivo cell therapy approaches, further strengthening Gilead’s oncology pipeline.

Management indicated that, upon FDA approval of anito-cel, the proposed transaction is expected to be accretive to earnings per share in 2028 and thereafter.

For investors, the acquisition highlights a broader trend in large-cap biotech capital deployment. Established companies are increasingly seeking full ownership of late-stage oncology assets to simplify economics, reduce long-term partnership obligations and consolidate strategic control ahead of potential commercialization milestones.

Cell therapy remains one of the most capital-intensive areas of oncology, requiring specialized manufacturing, logistics and commercial infrastructure. Gilead’s move signals confidence in both the asset and its ability to integrate development and commercialization within its existing cell therapy platform.

The next key inflection point will be the FDA’s review decision later this year, which will shape the commercial trajectory of anito-cel and the long-term impact of the acquisition.

Kratos Defense & Security (KTOS) – An Acquisition, Awards, and More


Monday, February 23, 2026

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms, and systems for United States National Security related customers, allies, and commercial enterprises. Kratos is changing the way breakthrough technologies for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research, and streamlined development processes. At Kratos, affordability is a technology, and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training and combat systems and next generation turbo jet and turbo fan engine development. For more information go to www.kratosdefense.com.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Acquisition. In a 424B3 filing, Kratos disclosed that it acquired Nomad Global Communication Solutions, Incorporated, for an initial amount of 972,136 KTOS shares or approximately $100 million. Nomad provides mobile command, control, and communications systems for space and satellite systems, UAVs, counter UAVs, and other systems, with clients including all branches of the U.S. armed forces, Homeland Security, and other Agencies, among others. We expect management to provide additional detail and color on the earnings call.

Drone Dominance. Kratos has been selected to participate in the initial Phase 1 Gauntlet for the Office of the Secretary of War’s Drone Dominance Program. This opportunity seeks to identify and evaluate platforms capable of demonstrating multiple one-way attack missions through a live competition. Upon successful completion of the Gauntlet, participants will be ranked and extended a prototype delivery award based on their performance and placement. The Drone Dominance Program represents a  $1.1 billion investment in groundbreaking unmanned systems technologies. The program aims to procure approximately 350,000 units.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

EuroDry (EDRY) – Finishing 2025 Strong; Building Momentum into 2026


Monday, February 23, 2026

EuroDry Ltd. was formed on January 8, 2018 under the laws of the Republic of the Marshall Islands to consolidate the drybulk fleet of Euroseas Ltd. into a separate listed public company. EuroDry was spun-off from Euroseas Ltd. on May 30, 2018; it trades on the NASDAQ Capital Market under the ticker EDRY. EuroDry operates in the dry cargo, drybulk shipping market. EuroDry’s operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company and Eurobulk (Far East) Ltd. Inc., which are responsible for the day- to-day commercial and technical management and operations of the vessels. EuroDry employs its vessels on spot and period charters and under pool agreements.

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Fourth quarter and full year results. EuroDry reported fourth-quarter net revenues of $17.4 million, exceeding our estimate of $16.5 million, driven by a stronger average TCE rate of $16,262 per day versus our $15,900 estimate and lighter drydocking of 13.7 days against our 22-day assumption. Adjusted EBITDA of $7.5 million and adjusted EPS of $0.88 came in ahead of our estimates of $6.7 million and $0.78, respectively. For the full year, net revenues of $52.3 million, adjusted EBITDA of $12.5 million, and an adjusted net loss of $2.50 per share all modestly surpassed our estimates of $51.4 million, $11.7 million, and a loss of $2.57.

Market update. Dry-bulk fundamentals strengthened in the fourth quarter, with average TCE rates rising to the highest levels in approximately two years. The global order book remains near historically low levels, at approximately 13.4% of the existing fleet, providing structural support. Near-term demand tailwinds include growing bauxite trade from West Africa, continued grain flows following the U.S.–China trade truce, and longer voyage distances due to Red Sea disruptions, though geopolitical uncertainty and tariff-related volatility remain risks.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Tidewater Doubles Down on Brazil With $500M Ultratug Offshore Deal

Tidewater Inc. (NYSE: TDW) is expanding its global offshore footprint with a $500 million all-cash acquisition of Wilson Sons Ultratug Participações S.A. and its affiliate Atlantic Offshore Services S.A. (collectively, “WSUT”). The transaction, which includes the assumption of approximately $261 million in existing debt, significantly scales Tidewater’s presence in Brazil—one of the world’s most active offshore energy markets.

The deal adds 22 platform supply vessels (PSVs) to Tidewater’s fleet. Pro forma for the acquisition, Tidewater will own 213 offshore support vessels (OSVs) and 231 total vessels globally, including crew boats, tug boats, and maintenance vessels.

The most immediate impact is geographic. Tidewater’s fleet in Brazil will expand from six vessels to 28, creating meaningful operating scale in a market widely viewed as structurally attractive due to sustained offshore development activity.

Notably, 19 of WSUT’s 22 PSVs are Brazilian-built. That distinction carries strategic weight. Brazilian-built vessels receive priority in local tenders and also provide access to Brazilian Special Registry (REB) tonnage rights. Through REB, Tidewater may import certain international-flagged vessels into Brazil while enjoying similar status to locally built ships.

In effect, the transaction provides both domestic positioning and optionality for additional fleet deployment.

WSUT brings approximately $441 million in existing backlog. According to Tidewater, many of those contracts are priced at day rates below current market levels, creating potential earnings leverage as contracts roll over.

Assuming a late second-quarter 2026 close, Tidewater expects the acquired business to generate roughly $220 million in revenue over the first twelve months, with gross margins around 58%. Annual G&A expenses are projected at approximately $14 million.

Management also characterized the deal as immediately accretive to 2026 and 2027 estimated earnings and free cash flow per share, though final outcomes will depend on closing timing, integration, and market conditions.

The acquisition will be funded with cash on hand. Tidewater intends to novate WSUT’s existing long-duration amortizing debt, provided by BNDES and Banco do Brasil, preserving what management describes as low-cost financing already embedded in the capital structure.

Following refinancing transactions in 2025 and this acquisition, Tidewater expects pro forma net leverage below 1.0x at closing, assuming a June 30, 2026 completion. A lower leverage profile could provide flexibility for future capital allocation decisions, subject to market conditions.

Brazil’s offshore sector remains one of the largest globally, with sustained activity in deepwater and pre-salt developments. Vessel supply dynamics, local content requirements, and regulatory structures create a market where scale and local tonnage matter.

For investors tracking the offshore services cycle, this transaction underscores a broader theme: operators are positioning for sustained utilization and disciplined fleet growth rather than speculative expansion. Consolidation also remains a key lever for improving operating leverage in a capital-intensive industry.

The transaction has been unanimously approved by Tidewater’s board and is expected to close late in the second quarter of 2026, pending regulatory approvals, including from Brazil’s antitrust authority (CADE).

As the offshore support vessel market continues to recalibrate following years of volatility, Tidewater’s Brazil-focused expansion signals confidence in long-term regional fundamentals—while also highlighting how capital structure discipline is shaping today’s consolidation playbook.

Supreme Court Strikes Down Trump’s Tariffs, Markets Rally as Trade Policy Shifts Again

The US trade landscape shifted abruptly Friday after the Supreme Court struck down the centerpiece of President Trump’s second-term tariff program, ruling 6–3 that the International Emergency Economic Powers Act (IEEPA) does not authorize the president to impose sweeping blanket tariffs. The decision immediately halts a massive portion of the tariffs announced last year on “Liberation Day,” dealing a significant blow to the administration’s trade strategy and sending stocks higher as investors recalibrated expectations for costs, inflation, and corporate margins.

“IEEPA does not authorize the President to impose tariffs,” Chief Justice John Roberts wrote in the majority opinion, rejecting the administration’s claim that the 1977 law granted broad authority to impose tariffs under a declared economic emergency. Roberts added that had Congress intended to grant such extraordinary tariff powers, it would have done so explicitly. The ruling upholds prior lower court decisions, including from the US Court of International Trade, that found the tariffs unlawful under that statute.

Markets responded swiftly. According to analysis from the Yale Budget Lab, the effective US tariff rate could now fall to 9.1%, down from 16.9% before the ruling. Investors interpreted the decision as reducing near-term cost pressures for companies that rely on imported goods and components. President Trump, however, quickly pushed back, calling the ruling “deeply disappointing” and criticizing members of the Court. Within hours, he announced plans to impose a 10% “global tariff” under Section 122 of the Trade Act of 1974, a provision that allows temporary tariffs of up to 15% for 150 days to address trade deficits. That authority has never previously been used to implement tariffs of this scale, and the administration signaled additional trade investigations under Section 301 may follow.

Notably, tariffs enacted under other legal authorities remain in place. Section 232 national security tariffs on steel, aluminum, semiconductors, and automobiles are unaffected, meaning a range of sector-specific import duties will continue. This layered approach underscores that while the Court invalidated one mechanism, trade tensions and tariff policy remain firmly in play.

An unresolved issue now looms over potential refunds. More than $100 billion — and possibly as much as $175 billion — in tariff revenue has been collected under IEEPA. The Court did not directly address refund eligibility, opening the door to further litigation and administrative action. Business groups, including the US Chamber of Commerce, are calling for swift refunds, arguing that repayment would meaningfully support small businesses and importers. Others caution that returning such sums could carry serious fiscal implications.

For small- and micro-cap investors, the ruling introduces both relief and renewed uncertainty. Smaller companies often operate with thinner margins and less pricing power than large multinational peers, making them particularly sensitive to import costs. A lower effective tariff rate could ease pressure on retailers, specialty manufacturers, and niche industrial firms that rely heavily on overseas inputs. At the same time, policy volatility remains elevated as the administration pivots to alternative tariff authorities, suggesting the trade environment may remain fluid.

The broader macro implications are equally significant. Reduced tariff pressure could temper inflation expectations, potentially influencing Federal Reserve policy — a key driver for small-cap performance given their sensitivity to financing conditions and domestic economic momentum.

Friday’s decision marks a major legal setback for the administration’s trade framework, but it does not signal an end to tariff-driven policy shifts. For small-cap investors, the near-term narrative may improve on cost relief, yet the longer-term trade outlook remains unsettled as Washington prepares its next move.

GDP Stumbles to 1.4% as Shutdown Slams Q4 Growth

The US economy ended 2025 on a weaker-than-expected note.

New data from the Bureau of Economic Analysis showed GDP grew at an annualized rate of just 1.4% in the fourth quarter, well below economist expectations for 2.9% growth. The miss marks a notable slowdown from earlier in the year and caps full-year 2025 growth at 2.2%, down from 2.8% in 2024.

A key culprit: government spending.

Federal outlays fell sharply during the quarter, reflecting the impact of the 43-day government shutdown that spanned October and November. Overall government spending declined at a 5.1% annualized rate, subtracting 0.9 percentage points from headline GDP. Federal spending alone plunged 16.6%, shaving 1.15 percentage points off growth.

President Trump, posting on Truth Social ahead of the release, argued the shutdown cost the economy “at least two points in GDP” and renewed calls for lower interest rates.

Under the Surface: Not All Weakness

Despite the headline disappointment, underlying private-sector demand remained more resilient.

Real final sales to private domestic purchasers — a key gauge of core demand — rose 2.4%, only slightly below the prior quarter’s 2.9% pace. Private fixed investment increased 2.6%, supported by continued spending on intellectual property and information processing equipment.

The AI build-out remains a meaningful contributor to growth. Spending on information processing equipment added 0.65 percentage points to GDP in the quarter, while investment in intellectual property products rose at a 7.4% pace.

However, consumer behavior showed signs of divergence. Services spending grew 3.4%, while goods spending fell 0.1%, underscoring a continued rotation away from physical goods.

What This Means for Small-Cap Stocks

For small- and micro-cap investors, the implications are layered.

First, government spending volatility tends to disproportionately impact smaller companies with federal exposure. Contractors, niche defense suppliers, and specialized service providers may have felt the brunt of delayed payments or paused contracts during the shutdown.

Second, slower headline GDP growth can pressure investor sentiment toward riskier asset classes — and small caps often sit at the front of that risk spectrum. The Russell 2000 historically reacts more sharply to growth scares than large-cap indices.

But there’s another side.

If economists are correct that shutdown-related drag reverses in the first quarter — with some forecasts calling for 3% growth in early 2026 — small caps could benefit from a rebound narrative. Lower rates, which the administration continues to push for, would also ease capital constraints for smaller companies that rely more heavily on credit markets.

And the ongoing AI investment cycle may continue to support smaller industrial, semiconductor-adjacent, and specialty tech names tied to infrastructure build-outs.

Bottom Line

The Q4 GDP miss highlights how policy disruptions can ripple through the broader economy. While headline growth slowed, core private demand and investment remain intact.

For small-cap investors, volatility may persist in the near term — but a rebound in government activity and continued capital investment could shift the narrative quickly in early 2026.

Travelzoo (TZOO) – Near Term Revenue Growth Throttles Back


Friday, February 20, 2026

Travelzoo® provides its 30 million members with exclusive offers and one-of-a-kind experiences personally reviewed by our deal experts around the globe. We have our finger on the pulse of outstanding travel, entertainment, and lifestyle experiences. We work in partnership with more than 5,000 top travel suppliers—our long-standing relationships give Travelzoo members access to irresistible deals.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Softer than expected Q4 Results. The company reported Q4 revenue of $22.5 million, an increase of 9%, and adj. EBITDA of $1.0 million, both of which were below our estimates of $23.0 million and $3.3 million, respectively.  Importantly, the modestly softer than expected results were largely driven by weakness in advertising and commerce revenue. Increased marketing spend and elevated G&A expenses due to a non-recurring corporate event adversely affected EBITDA.

Customer acquisition efficiency. Customer acquisition costs averaged $34 per member in Q4, compared to $28 in Q1, $38 in Q2, and $40 in Q3, reflecting continued investment in subscriber growth. Management highlighted rapid payback economics, with annual membership fees collected upfront and supplemented by transaction revenue. Acquisition costs are expensed immediately, impacting near-term profitability, though the strategy is intended to expand recurring revenue and strengthen the advertising platform over time.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Cocrystal Pharma (COCP) – CDI-988 Norovirus Phase 1 Data to be Presented at ICAR 2026


Friday, February 20, 2026

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

CDI-988 Data Selected For Presentation At ICAR. Cocrystal announced that it has been selected to present data from its Phase 1 clinical trial and updates from the ongoing Phase 1b challenge study testing CDI-988 against norovirus infection at the 38th International Conference on Antiviral Research, to be held April 27 to May 1 in Prague, Czech Republic. We see the presentation at this important conference as recognition of the potential of CDI-988 for an indication that has serious medical and economic consequences.

Phase 1 and 1b Data Expected. We expect Dr. Sam Lee, President and Co-CEO, to present initial Phase 1 safety and tolerability data. Previously announced data from the single ascending dose (SAD) and multiple ascending dose (MAD) study showed safety and tolerability across all dose cohorts tested. Additional data from the ongoing Phase 1b norovirus challenge study testing CDI-988 as both a prophylactic and therapeutic may also be included.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Cardinal Infrastructure Expands into Georgia with A.L. Grading Acquisition, Accelerating Southeast Growth Strategy

Cardinal Infrastructure Group, Inc. (NASDAQ: CDNL) announced the acquisition of A.L. Grading Contractors, a Sugar Hill, Georgia-based grading and site development services provider, marking a significant step in the company’s expansion beyond its North Carolina roots and reinforcing its acquisition-led growth strategy.

The transaction adds a well-established regional contractor with approximately $160 million in annual sales to Cardinal’s platform. For a recently public small-cap company, the deal meaningfully increases geographic reach while strengthening service capabilities in grading, utilities, and residential site preparation across one of the fastest-growing regions in the Southeast.

Cardinal went public in late 2025 with a stated objective of building a scaled civil infrastructure operator through a combination of organic growth and targeted acquisitions. The addition of A.L. Grading aligns squarely with that strategy. Georgia’s population growth, housing demand, and ongoing development activity provide a sizable runway for infrastructure and site development work, giving Cardinal exposure to a broader pipeline of public and private projects.

The company also provided preliminary 2025 operating results alongside the acquisition announcement, signaling strong underlying momentum. Cardinal expects full-year revenue in the range of approximately $452 million to $460 million, representing roughly 45% year-over-year growth. Backlog expanded more than 30%, providing improved revenue visibility entering 2026. Those metrics suggest the company is not relying solely on M&A to drive growth but is also benefiting from strong project execution and demand fundamentals.

For small-cap investors, the combination of accelerating organic performance and disciplined bolt-on acquisitions can be particularly compelling. Infrastructure services is a fragmented sector, especially at the regional level. Operators with access to public capital and a scalable platform often have the opportunity to consolidate smaller private contractors, extract operating efficiencies, and improve bidding capacity on larger, multi-state contracts.

The acquisition also enhances Cardinal’s competitive positioning. With a larger footprint and expanded capabilities, the company can pursue more complex projects and serve developers operating across state lines. Geographic diversification may also help smooth revenue volatility tied to local permitting cycles or municipal spending patterns.

Importantly, this move comes at a time when capital markets remain selective for small-cap issuers. Companies demonstrating tangible growth, backlog expansion, and integration discipline are more likely to attract investor support. Cardinal’s ability to announce both a meaningful acquisition and strong forward outlook in the same update positions it as an emerging consolidator in the Southeast civil construction space.

While integration risk is always present in acquisition-driven strategies, the industrial services model often lends itself to scalable roll-ups when executed carefully. For Cardinal, expanding into Georgia represents more than a one-off transaction—it signals intent to build a broader regional infrastructure platform.

As infrastructure investment and residential development remain key economic drivers in the Southeast, Cardinal’s latest acquisition underscores how small-cap industrial companies can leverage public market access to accelerate growth and expand market share in fragmented sectors

Hims & Hers to Acquire Eucalyptus in $1.15 Billion Deal to Expand Global Digital Health Footprint

Hims & Hers Health, Inc. has announced a definitive agreement to acquire Eucalyptus in a transaction valued at up to $1.15 billion, marking one of the most significant global expansion moves in the consumer telehealth sector to date. The deal positions Hims & Hers to accelerate its ambition of becoming the leading global consumer health platform, extending its reach well beyond the United States.

Under the terms of the agreement, approximately $240 million will be paid in cash at closing, with the remaining consideration structured as deferred payments and performance-based earnouts through early 2029. The company has emphasized that the transaction is designed to preserve balance sheet flexibility, with most of the funding expected to come from existing cash reserves and future U.S. operating cash flows. The acquisition is subject to regulatory approvals and is anticipated to close in mid-2026.

The strategic logic behind the transaction is straightforward: scale, infrastructure, and international expertise. Eucalyptus operates a portfolio of digital health brands across Australia, the United Kingdom, Germany, Japan, and Canada, and has served more than 775,000 customers. With an annual revenue run-rate exceeding $450 million and triple-digit year-over-year ARR growth throughout 2025, Eucalyptus brings both growth momentum and operational discipline to the combined platform.

For Hims & Hers, whose U.S. platform has built a reputation for direct-to-consumer access to personalized treatments across areas such as mental health, dermatology, sexual health, and weight management, the deal creates a ready-made international footprint. Rather than entering new markets from scratch, the company gains regulatory expertise, localized clinical infrastructure, and established consumer brands in key geographies.

Chief Executive Officer Andrew Dudum framed the acquisition as the next logical step in the company’s evolution, emphasizing that while healthcare challenges are universal, solutions must be tailored regionally. By integrating Eucalyptus’ local operating model with Hims & Hers’ technology platform and brand infrastructure, the company aims to expand access to personalized care globally while maintaining clinical quality and compliance standards.

Eucalyptus’ credibility adds weight to the expansion strategy. The company has facilitated nearly two million consultations and has published more than 20 peer-reviewed studies examining patient outcomes and adherence. It is also the first Australian telehealth provider accredited by the Australian Council on Healthcare Standards, underscoring its regulatory and clinical rigor.

Leadership continuity appears central to the integration plan. Eucalyptus CEO Tim Doyle will join Hims & Hers as Senior Vice President of International, overseeing global operations outside the U.S. His experience scaling digital healthcare businesses across multiple regulatory environments is expected to be instrumental as the company pushes deeper into Europe and Asia-Pacific markets.

From a competitive standpoint, the acquisition strengthens Hims & Hers’ position as pharmaceutical manufacturers, biotech firms, and diagnostic companies increasingly seek scalable digital distribution partners. The combined entity will offer capabilities ranging from online pharmacy fulfillment to concierge-style telehealth services, broadening its appeal across therapeutic categories.

If successfully executed, the deal could establish category leadership in Australia and meaningfully expand market share in the UK and Germany within the next two years. More broadly, it signals that consumer-centric digital health platforms are entering a new phase of consolidation and global ambition.

For investors and industry observers alike, this transaction is less about short-term expansion and more about building infrastructure for long-term dominance in global consumer healthcare.

Power Metallic Mines Inc. (PNPNF) – Recent Assay Results and Observations from the Summer-Fall 2025 Drilling Program


Thursday, February 19, 2026

Power Metallic is a Canadian exploration company focused on advancing the Nisk Project Area (Nisk–Lion–Tiger)—a high–grade Copper–PGE, Nickel, gold and silver system—toward Canada’s next polymetallic mine. On 1 February 2021, Power Metallic (then Chilean Metals) secured an option to earn up to 80% of the Nisk project from Critical Elements Lithium Corp. (TSX–V: CRE). Following the June 2025 purchase of 313 adjoining claims (~167 km²) from Li–FT Power, the Company now controls ~212.86 km² and roughly 50 km of prospective basin margins. Power Metallic is expanding mineralization at the Nisk and Lion discovery zones, evaluating the Tiger target, and exploring the enlarged land package through successive drill programs. Beyond the Nisk Project Area, Power Metallic indirectly has an interest in significant land packages in British Columbia and Chile, by its 50% share ownership position in Chilean Metals Inc., which were spun out from Power Metallic via a plan of arrangement on February 3, 2025. It also owns 100% of Power Metallic Arabia which owns 100% interest in the Jabul Baudan exploration license in The Kingdon of Saudi Arabia’s JabalSaid Belt. The property encompasses over 200 square kilometres in an area recognized for its high prospectivity for copper gold and zinc mineralization. The region is known for its massive volcanic sulfide (VMS) deposits, including the world-class Jabal Sayid mine and the promising Umm and Damad deposit.

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Expanding the High-Grade Core at Lion. Summer-Fall 2025 drilling successfully extended high-grade mineralization down plunge at the Lion Zone, with impressive intercepts including 8.40 meters grading 8.05% copper equivalent recovered, and 5.10 meters grading 9.86% copper equivalent recovered, reinforcing strong vertical continuity.

Precious Metals Significantly Enhance Value. Assays revealed substantial palladium, platinum, and gold contributions, materially boosting copper-equivalent grades and highlighting the robust polymetallic nature of the deposit.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.